Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.4B | 5.1B | 5.1B | 5.4B |
Cost of revenue | 3.1B | 3.0B | 3.2B | 3.1B |
Gross profit | 2.3B | 2.1B | 1.9B | 2.3B |
Operating expense | ||||
Research & development | 245.5M | 242.9M | 240.3M | 229.3M |
Selling general and admin | 1.1B | 805.4M | 766.2M | 905.1M |
Other operating expenses | — | — | — | — |
Operating income | 974.2M | 1.1B | 924.7M | 1.1B |
Non operating interest income | ||||
Income | 42.6M | 67.3M | 78.4M | 91.2M |
Expense | 202.0M | 217.3M | 214.8M | 235.2M |
Other income expense | -28.1M | 268.5M | -141.5M | 489.2M |
Pretax income | 786.7M | 1.2B | 646.9M | 1.5B |
Tax provision | 208.8M | 225.9M | 28.1M | 296.6M |
Net income | 617.9M | 956.3M | 620.5M | 1.2B |
Basic EPS | 1.4 | 2.1 | 1.3 | 2.5 |
Diluted EPS | 1.3 | 2.0 | 1.3 | 2.5 |
Basic average shares | 458.0M | 463.5M | 463.3M | 469.3M |
Diluted average shares | 460.8M | 466.8M | 465.6M | 471.1M |
EBITDA | 1.2B | 1.4B | 1.2B | 1.5B |
Net income from continuing op. | 617.9M | 956.3M | 620.5M | 1.2B |
Minority interests | -1.7M | -5.1M | 0 | -3.4M |
Preferred stock dividends | — | — | — | — |